Baker Bros. Advisors — Unmapped CUSIP
How Baker Bros. Advisors's position in First Tracks Biotherapeutics changed quarter by quarter. Change badges compare each quarter to the fund's immediately-prior filing. CUSIP 337185102 needs mapping
- Quarters held
- 1
- First reported
- Q3 2026
- Latest value
- $16,760,710
- Latest weight
- 0.1%
- Peak weight
- 0.1%
- Shares since first
- 0%
Position Trend
Shares, value, and weight from first report to latest report.
Baker Bros. Advisors first reported 472,932 shares in Q3 2026 and most recently reported 472,932 shares in Q3 2026. Portfolio weight peaked at 0.1% in Q3 2026; the low reported weight was 0.1% in Q3 2026.
Since the first report, shares are 0% and reported value is 0%. Latest move: Newly reported
| Quarter | Shares | Value | % of portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | 472,932 | $16,760,710 | 0.08% | Newly reported |